
Pofol200 mg/20
Popular Pharmaceuticals Ltd.
Propofol is a short-acting intravenous sedative-hypnotic agent used in anesthesia and critical care.
Propofol is a short-acting intravenous sedative-hypnotic agent used in anesthesia and critical care. Its evidence-based uses include:
Propofol is not indicated for use outside settings equipped for airway management and cardiorespiratory monitoring.
| Patient group | Dose |
|---|---|
| Healthy adults <55 years (ASA I-II) | 2-2.5 mg/kg IV, titrated over 20-40 seconds until onset of anesthesia |
| Elderly, debilitated, or ASA III-IV patients | 1-1.5 mg/kg IV, given more slowly |
| Hemodynamically unstable/cardiac patients | 0.5-1.5 mg/kg IV, titrated cautiously |
Continuous infusion of 100-200 mcg/kg/min (6-12 mg/kg/hour), or intermittent bolus of 25-50 mg, titrated to clinical effect; lower rates (50-100 mcg/kg/min) are used in elderly or debilitated patients.
Initial infusion of 25-75 mcg/kg/min for 3-5 minutes or slow injection of 0.5 mg/kg over 3-5 minutes, followed by maintenance infusion of 5-50 mcg/kg/min, titrated to the desired level of sedation.
Initiate at 5 mcg/kg/min (0.3 mg/kg/hour) for at least 5 minutes; increase in increments of 5-10 mcg/kg/min over 5-10-minute intervals until the desired sedation level is reached. Maintenance is usually 5-50 mcg/kg/min (0.3-3 mg/kg/hour); doses above 4 mg/kg/hour are not generally recommended unless the potential benefit is judged to outweigh risk, given the association with Propofol Infusion Syndrome (see Precautions and Warnings).
Induction of anesthesia (patients ≥3 years): 2.5-3.5 mg/kg IV, given more slowly than in adults; lower doses may be needed in children classified as ASA III-IV. Maintenance (patients ≥2 months): infusion rates are generally higher than in adults, in the range of 125-300 mcg/kg/min, titrated to effect. Propofol is not approved for ICU sedation in pediatric patients and is not recommended for induction of anesthesia in children under 3 years of age.
Propofol must be administered only by persons trained in general anesthesia and not involved in the conduct of the surgical/diagnostic procedure, with continuous monitoring of cardiovascular and respiratory function and immediate availability of airway management equipment. Strict aseptic technique is mandatory when handling the emulsion (see Precautions and Warnings).
Very common/common: pain, burning, or stinging at the injection site; hypotension; transient apnea during induction; bradycardia; involuntary movements; headache; nausea and vomiting on emergence.
Less common but clinically important: hypertension, arrhythmias, hyperlipidemia/hypertriglyceridemia with prolonged infusion, urine discoloration (green, pink, or cloudy - benign metabolite effect), thrombophlebitis, and rare anaphylactoid/anaphylactic reactions.
Rare but serious: severe bradycardia and asystole, pulmonary edema, seizure-like activity/opisthotonos on emergence, and Propofol Infusion Syndrome with prolonged high-dose ICU infusion (see Precautions and Warnings for details).
Propofol is contraindicated in patients with:
Propofol should not be used for obstetric anesthesia/analgesia during labor and delivery except under specific specialist circumstances, as it readily crosses the placenta and can cause neonatal depression; this is a use-restriction rather than a general absolute contraindication and should be assessed case-by-case by the treating anesthesiologist.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.